MD3202F1 - Metoda de pronosticare a sterilitatii la femei - Google Patents

Metoda de pronosticare a sterilitatii la femei Download PDF

Info

Publication number
MD3202F1
MD3202F1 MDA20060051A MD20060051A MD3202F1 MD 3202 F1 MD3202 F1 MD 3202F1 MD A20060051 A MDA20060051 A MD A20060051A MD 20060051 A MD20060051 A MD 20060051A MD 3202 F1 MD3202 F1 MD 3202F1
Authority
MD
Moldova
Prior art keywords
factors
sterility
group
refers
values
Prior art date
Application number
MDA20060051A
Other languages
English (en)
Other versions
MD3202G2 (ro
Inventor
Valentina Smugurov
Original Assignee
Valentina Smugurov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valentina Smugurov filed Critical Valentina Smugurov
Priority to MDA20060051A priority Critical patent/MD3202G2/ro
Publication of MD3202F1 publication Critical patent/MD3202F1/ro
Publication of MD3202G2 publication Critical patent/MD3202G2/ro

Links

Landscapes

  • Image Analysis (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

Inventia se refera la medicina, si anume la ginecologie si este destinata pentru determinarea sterilitatii la nulipare. Metoda, conform inventiei, consta in aceea ca se releva urmatorii factori: varsta, statutul social, influenta factorilor nefavorabili ai mediului de producere, deprinderile daunatoare, frecventa patologiilor extragenitale si genitale, dereglarile ciclului menstrual, metodele contraceptive, starea ginecologica, interventiile chirurgicale asupra organelor din cavitatea abdominala, inclusiv asupra organelor genitale, avorturi, nasteri. Factorilor relevati li se atribuie anumitevalori. Se sumeaza valorile tuturor factorilor relevati, apoi suma se imparte la numarul de factorianalizati si in cazul in care valoarea obtinuta este mai mica de 2,1, se face pronosticul ca femeiase refera la grupul cu lipsa riscului de sterilitate, daca este egala cu 2,1...3,7, atunci se refera la grupul care necesita atentie, iar daca este mai mare de 3,7, atunci la grupul cu risc sporit.
MDA20060051A 2006-02-13 2006-02-13 Metodă de pronosticare a sterilităţii la femei MD3202G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20060051A MD3202G2 (ro) 2006-02-13 2006-02-13 Metodă de pronosticare a sterilităţii la femei

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20060051A MD3202G2 (ro) 2006-02-13 2006-02-13 Metodă de pronosticare a sterilităţii la femei

Publications (2)

Publication Number Publication Date
MD3202F1 true MD3202F1 (ro) 2006-12-31
MD3202G2 MD3202G2 (ro) 2007-07-31

Family

ID=37607298

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20060051A MD3202G2 (ro) 2006-02-13 2006-02-13 Metodă de pronosticare a sterilităţii la femei

Country Status (1)

Country Link
MD (1) MD3202G2 (ro)

Also Published As

Publication number Publication date
MD3202G2 (ro) 2007-07-31

Similar Documents

Publication Publication Date Title
Tepper et al. Update to CDC's US Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV.
Ridley et al. Effect of body mass index on patients with multiligamentous knee injuries
MY168748A (en) Anti-asic1 antibodies and uses thereof
EA200801698A1 (ru) Лекарственные композиции для применения в вагине
MD3202F1 (ro) Metoda de pronosticare a sterilitatii la femei
IN2014CN00379A (ro)
Tabassum et al. Pattern of female gynecological malignancies in south Punjab Region of Pakistan: An overview of 5 years.
CN103300493A (zh) 一种红光丰胸内衣
MD3925F1 (ro) Metoda de pronosticare a sterilitatii la barbati
MA31385B1 (fr) Utilisation d'inhibiteurs de hdac pour le traitement de la destruction osseuse
WO2014181115A3 (en) Cgb2 and cgb1 genes; diagnosis, monitoring and treatment of cancer
ATE288755T1 (de) Tetrahydrochinolin-derivate zur behandlung von krankheiten ausgelöst durch zu hohem oder zu niedrigem oestrogenspiegel
CN103041293B (zh) 一种治疗阴虚内热型肺癌的中药汤剂
MD2850F1 (ro) Metoda de inducere a avortului medicamentos
AU2012100620A4 (en) Hospital help
Pajardi et al. Camptodactyly: Early nonoperative treatment
Omole-Ohonsi Risk factors for cervical dysplasia in Aminu Kano Teaching Hospital
Sohrabi Why Focusing on Social Determinants of Health?
RU79023U1 (ru) Комплект белья, преимущественно, послеродовой
Oh et al. Demographic and Health-related Risk Factors for the Recurrence of Primary Spontaneous Pneumothorax
CN204292263U (zh) 一种隐私保护衣
MD291Y (ro) Metoda de pronostic al aparitiei efectelor adverse la protezarea auditiva
CN201684063U (zh) 一种多功能子宫托
CN201469486U (zh) 新型艾滋病防治装置
Kimak et al. 31 Home Contact and Satisfaction with Postpartum Care

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees